InsidersTradesSigma
Discover the complete record of transactions filed by Gaspar Bobby, 首席执行官. Director active across 1 company, notably Orchard Therapeutics plc. In total, 1 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €10k. History available since 1 April 2022. The latest transaction was disclosed on 1 April 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 条申报中的 1 条
Bobby Gaspar is the Chief Executive Officer of Orchard Therapeutics plc, a biopharmaceutical company. He leads the company's operations and strategy, focusing on the development of innovative therapies. His expertise in the biopharmaceutical sector is essential for the company's growth.